BINGO.... sir Iniciorulez Spot on and I can’t see this going down any other way. Gilead may lose big time.... Richard is like a cowboy and he lassoed the big boys and he is ready to strike. It’s wild see how how the toxic big pharma lost to the long Cydy game. Richard played with the big boys, got the results, secured global Patents and then kicked them to the curb for a superior molecule vs toxic chemistry.
We now need to think of Richard as our Trojan horse.
Take a look at Diffusion Pharmaceuticals chart. DFFN. They did a reverse split on Friday, 12/14/2018....and look what has happened to the stock price since then. The day traders have a field day with it. Not sure a RS is the way to go, at least not yet. Too many things coming down the pipeline for Leronlimab that will change the dynamics here. It's not like CYDY is a NASDAQ company that must RS to regain compliance.... Lets see what the 1Q 2019 brings and go from there, IMO.
Shorts love reverse splits. I am not in favor of one. This debate has taken place here b4 and it is a 50/50 split as to those for and against. I would lighten if RS were announced and wait for the smoke to clear.
News 
Market Data 
Discover 
